Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
557
datasets available to search
ShareScore release 0.9.0
Dataset results
557 results for “Imatinib”
Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.
ClinicalTrials.gov study NCT06087263. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib Therapy
ClinicalTrials.gov study NCT02461849. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00744081. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib
ClinicalTrials.gov study NCT01694277. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Pilot Study of Imatinib Cetuximab Combo for H & N Cancer
ClinicalTrials.gov study NCT05816785. IPD Sharing: YES. Countries: 1. Publications: 0.
Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma
ClinicalTrials.gov study NCT00904735. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive
ClinicalTrials.gov study NCT00763763. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma
ClinicalTrials.gov study NCT00314873. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma
ClinicalTrials.gov study NCT01782508. IPD Sharing: Not stated. Countries: 1. Publications: 0.
to Evaluate the Pharmacokinetics(Cmax, Auc) of CJ Imatinib Mesylate Tablet 200mg x 1 Compared With Gleevec Film-coated Tablet 100mg x 2 in Healthy Male Volunteers
ClinicalTrials.gov study NCT01926548. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT03343600. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan
ClinicalTrials.gov study NCT00337454. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
ClinicalTrials.gov study NCT00042016. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma
ClinicalTrials.gov study NCT00881049. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib
ClinicalTrials.gov study NCT02398825. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor
ClinicalTrials.gov study NCT07171203. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria
ClinicalTrials.gov study NCT02614404. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT01227135. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors
ClinicalTrials.gov study NCT00427583. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL
ClinicalTrials.gov study NCT05071482. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.